One-time universal screening for hepatitis B could save 23K lives, nearly $600 million
One-time universal screening for hepatitis B could save 23K lives, nearly $600 million
A one-time, universal screening for chronic hepatitis B infection could prevent 23,000 additional deaths from chronic HBV-related liver disease and save almost $600 million, according to a study in Clinical Infectious Diseases.
“The study was prompted by the Division of Viral Hepatitis at the CDC to assess the economic and population health impact of a recommendation potentially to screen all adults in the United States for chronic hepatitis B infection(CHB),” Samuel So, MBBS, FACS, who founded the liver cancer program at the Stanford Cancer Center, told Healio.